Strange: Bullish NKTR Analysts Actually See -28.11% Downside
December 11, 2017 at 09:13 AM EST
Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Nektar Therapeutics (NKTR). The average 12-month price target for NKTR averaging the work of 5 analysts reveals an average price target of $38.80/share..